Luca Issi
Stock Analyst at RBC Capital
(0.49)
# 4,203
Out of 4,596 analysts
678
Total ratings
38.8%
Success rate
-2.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintained: Hold | $45 | $56.11 | -19.80% | 39 | Jul 31, 2026 | |
| ALNY Alnylam Pharmaceuticals | Rated: Buy | $445 → $350 | $216.24 | +61.86% | 65 | Jul 30, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Hold | $32 | $30.45 | +5.11% | 8 | Jul 30, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $15 | $5.51 | +172.23% | 28 | Jul 30, 2026 | |
| AMGN Amgen | Maintained: Buy | $370 | $376.09 | -1.62% | 12 | Jul 29, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $87 → $100 | $84.05 | +18.98% | 39 | Jul 29, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $85 | $53.40 | +59.18% | 41 | Jul 29, 2026 | |
| QURE uniQure | Reiterated: Buy | $65 | $43.83 | +48.30% | 44 | Jul 29, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $30 → $35 | $25.04 | +39.78% | 12 | Jul 29, 2026 | |
| ARGX argenx SE | Rated: Buy | $945 → $1,025 | $828.39 | +23.73% | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $732.00 | - | 2 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $66 → $62 | $59.95 | +3.42% | 36 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $40 | $24.80 | +61.29% | 19 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $275 → $280 | $244.81 | +14.37% | 16 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $80.15 | +24.77% | 3 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $4 | $3.66 | +9.29% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.0825 | +2,324.24% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $9.83 | +93.29% | 39 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.82 | +395.87% | 32 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $10.65 | +40.85% | 36 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.18 | +379.04% | 14 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $10.66 | -24.95% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $25.99 | +0.04% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.46 | +584.93% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.60 | +54.14% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $49.17 | +1.69% | 29 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $11.69 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $54 | $15.53 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $5.11 | n/a | 7 | Mar 21, 2023 |
Moderna
Jul 31, 2026
Maintained: Hold
Price Target: $45
Current: $56.11
Upside: -19.80%
Alnylam Pharmaceuticals
Jul 30, 2026
Rated: Buy
Price Target: $445 → $350
Current: $216.24
Upside: +61.86%
Agios Pharmaceuticals
Jul 30, 2026
Maintained: Hold
Price Target: $32
Current: $30.45
Upside: +5.11%
Wave Life Sciences
Jul 30, 2026
Maintained: Buy
Price Target: $15
Current: $5.51
Upside: +172.23%
Amgen
Jul 29, 2026
Maintained: Buy
Price Target: $370
Current: $376.09
Upside: -1.62%
Arrowhead Pharmaceuticals
Jul 29, 2026
Maintained: Buy
Price Target: $87 → $100
Current: $84.05
Upside: +18.98%
Ionis Pharmaceuticals
Jul 29, 2026
Reiterated: Buy
Price Target: $85
Current: $53.40
Upside: +59.18%
uniQure
Jul 29, 2026
Reiterated: Buy
Price Target: $65
Current: $43.83
Upside: +48.30%
Dyne Therapeutics
Jul 29, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $25.04
Upside: +39.78%
argenx SE
Jul 23, 2026
Rated: Buy
Price Target: $945 → $1,025
Current: $828.39
Upside: +23.73%
Jul 23, 2026
Maintained: Buy
Price Target: n/a
Current: $732.00
Upside: -
Jul 7, 2026
Maintained: Hold
Price Target: $66 → $62
Current: $59.95
Upside: +3.42%
Jul 7, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $24.80
Upside: +61.29%
Jul 7, 2026
Maintained: Buy
Price Target: $275 → $280
Current: $244.81
Upside: +14.37%
Jul 7, 2026
Maintained: Buy
Price Target: $100
Current: $80.15
Upside: +24.77%
Jun 2, 2026
Maintained: Hold
Price Target: $10 → $4
Current: $3.66
Upside: +9.29%
May 14, 2026
Maintained: Hold
Price Target: $2
Current: $0.0825
Upside: +2,324.24%
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $9.83
Upside: +93.29%
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $1.82
Upside: +395.87%
May 11, 2026
Maintained: Hold
Price Target: $15
Current: $10.65
Upside: +40.85%
May 11, 2026
Maintained: Buy
Price Target: $20
Current: $4.18
Upside: +379.04%
May 8, 2026
Maintained: Hold
Price Target: $8
Current: $10.66
Upside: -24.95%
May 8, 2026
Maintained: Hold
Price Target: $26
Current: $25.99
Upside: +0.04%
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
May 5, 2026
Maintained: Hold
Price Target: $4
Current: $2.60
Upside: +54.14%
May 4, 2026
Maintained: Hold
Price Target: $50
Current: $49.17
Upside: +1.69%
Nov 13, 2024
Maintained: Buy
Price Target: $9 → $11
Current: $11.69
Upside: n/a
May 11, 2023
Maintained: Hold
Price Target: $3 → $54
Current: $15.53
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $4 → $3
Current: $5.11
Upside: n/a